arrow
E

Elisa Menozzi

UCL Queen Square Institute of Neurology
H指数:16
被引数:885

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Ambroxol for Parkinson's Disease

Ambroxol用于帕金森病

2026-11-100
PRE
Microbiome signature of Parkinson's disease in healthy and genetically at-risk individuals

Menozzi, E.; Ren, Y.; Geiger, M.; Macnaughtan, J.; Avenali, M.; Toffoli, M.; Schapira, A.H.V. 帕金森病的微生物组特征:在健康个体和遗传易感个体中的表现。Nat. Med. 2026. online ahead of print. [Google Scholar] [CrossRef]

2026-04-011
OA
Protocol of ASPro-PD: a phase 3 trial of ambroxol to slow progression in genetically stratified Parkinson’s disease

ASPro-PD方案:一项关于ambroxol延缓基因分层帕金森病患者病程进展的III期临床试验

2026-02-180
OAAI
Severe GBA1 variants drive the GBA1-PD clinical phenotype: implications for counselling and clinical trials

GBA1基因严重变异驱动GBA1-PD临床表型:对遗传咨询和临床试验的启示

2025-10-010
OAAI
Exploring the relationship between GBA1 host genotype and gut microbiome in the GBA1L444P/WT mouse model: implications for Parkinson’s disease pathogenesis

探索GBA1宿主基因型与肠道微生物组在GBA1L444P/WT小鼠模型中的关系:对帕金森病发病机制的启示

2025-10-010
OAAI
Phenotypic effect of GBA1 variants in individuals with and without Parkinson's disease: The RAPSODI study
2023-11-016
OAAI
Long-term effects of subthalamic nucleus deep brain stimulation on speech in Parkinson's disease (vol 13, 11462, 2023)
2023-08-170
OAAI
Long-term effects of subthalamic nucleus deep brain stimulation on speech in Parkinson's disease
2023-07-152
OAAI
Freezing of Gait in Parkinson's Disease Patients Treated with Bilateral Subthalamic Nucleus Deep Brain Stimulation: A Long-Term Overview
2022-09-076
OAAI